Related Experiment Video
Updated: May 21, 2025

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
A scoping review identifies comments suggesting modifications to PRISMA-P 2015.
Camilla Hansen Nejstgaard1, Nina Sondrup1, An-Wen Chan2
1Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Open Patient Data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Published comments on the PRISMA-P 2015 guideline suggest modifications and new items, particularly for eligibility criteria and data synthesis. These insights will inform the upcoming update of the Preferred Reporting Items for Systematic reviews and Meta-Analyses Protocols guideline.
Area of Science:
- Systematic review methodology
- Research reporting guidelines
Background:
- The PRISMA-P (Preferred Reporting Items for Systematic reviews and Meta-Analyses Protocols) 2015 guideline provides a framework for reporting systematic review protocols.
- Published comments offer valuable feedback for refining reporting standards.
Purpose of the Study:
- To systematically identify, summarize, and analyze comments related to the PRISMA-P 2015 guideline.
- To specifically identify suggestions for modifying the existing guideline.
Main Methods:
- Searched multiple bibliographic databases and other sources (e.g., BMJ rapid responses, BMC Blog Network) from 2015 to 2024.
- Included 28 documents containing 38 relevant comments, categorizing them as modifications, new items, deletions, or additional comments.
- Analyzed comment themes, rationales, and alignment with current PRISMA-P 2015 guidance.
Main Results:
- Eleven comments suggested modifications to existing PRISMA-P 2015 items, notably concerning eligibility criteria and data synthesis.
- Eleven comments proposed new items, with the data items section receiving the most suggestions.
- No comments suggested deleting existing items; most provided rationales and requested expanded guidance.
Conclusions:
- Feedback highlights areas for improvement in the PRISMA-P 2015 guideline, particularly regarding eligibility criteria and data synthesis.
- The identified issues provide context for users and will inform the planned update of the PRISMA-P guideline.
Related Concept Videos
Methods of Documentation II: POMR
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

